News und Analysen
Starbucks stock is suddenly surrounded by analysts
The answer everyone is looking for in today's market is one that potentially positions portfolios in a way to benefit from the coming FED interest rate cuts in 2024. Because markets are
UniFirst stock falls into the buy zone
UniFirst (NYSE: UNF) had a decent first quarter but provided weak guidance, sending shares down nearly 10%. As bad as the move sounds, it’s a knee-jerk reaction in a stock whose future is bright
5 Reasons Under Armour stock may not trade under $10 for long
On two occasions last year, Under Armour, Inc. (NYSE:UAA) came within pennies of recovering to the $10.00 level. In 2024, the third time may not only be the charm but also unleash an extra large
4 takeaways from the first day of trading in 2024
The first day of 2024 trading has come and gone, and the signs they sent are not good. Between market leaders confirming a top, the S&P 500 (NYSEARCA: SPY) retreating, and the VIX (NDEXCBOE: VIX)
Intel stock: Analysts are expecting multi-year highs
After falling more than 50% in 2022, last year really was all about the recovery for shares of Intel Corporation (NASDAQ: INTC). They climbed throughout the year, finishing up about 100% from
Traders are suddenly stampeding these Buffett stocks
The new year is here, and some are already calling the shots about how 2024 could look. Who dominates? It will likely experience a 'trader' market in the first quarter of 2024, considering where
AT&T could be the best placeholder stock before rate cuts come
A significant shift is about to come to the financial markets, as the forces that push and pull stock prices are pivoting from one end to the opposite in the coming months. Interest rates act as a
Will cost cuts be enough for Hasbro to thrive in 2024?
Global toy and entertainment company Hasbro Inc. (NYSE: HAS) had a weak 2023 as shares fell 17.5% compared to the 24.8% gain for the S&P 500 index. It also underperformed rival Mattel Inc. (NYSE:
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Kaufsignal. 297% Biotech Aktientip nach 15.973% mit BioNTech
03.01.24
London (www.aktiencheck.de, Anzeige)
Link
Amprius Technologies amps the market and enters a reversal
Amprius Technologies (NYSE: AMPX) stock price action over the past year or so is not surprising. It is an early-stage tech start-up whose IPO left little meat on the bone for new investors
Analysts suddenly say Google is the place to be in
Very few times in history have investors come across a stock that offers the sort of moat that Warren Buffett could salivate over, a strong business with solid financials and a structure
One fast-food stock is expected to outperform all others in 2024
With a 20% rally under its belt since October, it goes without saying that McDonald's Corp (NYSE: MCD) is coming into 2024 looking pretty hot. After a disappointing Q3 threatened to spiral out of
PepsiCo's dividend won't last long in today's market
Markets shift according to a straightforward selection process; as money becomes interested in better instruments or investments, money as a whole begins to rotate into different areas of the
4 reasons to buy Dutch Bros stock over Starbucks
Drive-thru coffee and beverage operator Dutch Bros Inc. (NASDAQ: BROS) stock has more upside than the incumbent behemoth Starbucks Co. (NASDAQ: SBUX) on a percentage basis. Its newly minted CEO
New price targets could erase Cisco's 3.1% dividend yield soon
A new FED has come into play to end 2023 with a major surprise for most investors out there trying to find a direction to bet on and the implications this new view has are plenty, but today, you
Is the Apple Watch ban the tipping point?
Apple Inc. (NYSE: AAPL) had a stellar 2023, gaining 49.39% for 2023 while maintaining the largest weighting in the S&P 500. While the technology sector juggernaut continues to grow, its sales have
3 mega caps with RSIs that point to big Q1s
With the S&P 500 index on the verge of hitting an all-time high and many others already there, it's no surprise that investors are enjoying strong year-end rallies. Indeed, all signs point to 2023
Celsius stock in actionable zone as big investors ramp up buying
Energy drink maker Celsius Holdings Inc. (NASDAQ: CELH) has been a fast mover since its 2017 IPO and may offer an early buy opportunity.
The Celsius chart shows the stock consolidating above its
Microsoft is new cybersecurity titan, challenging big tech rivals
You might not think of Microsoft Corp. (NASDAQ: MSFT) as a leader in the cybersecurity space, but the company has been making big strides in that part of the tech industry.
As with many business
Synopsys stock: Unsung hero of the AI revolution
Synopsys Inc. (NASDAQ: SNPS), maker of semiconductor design software, created a buzz recently when it offered to buy engineering software maker Ansys Inc. (NASDAQ: ANSS).
Synopsys isn’t a
Apple stock is institutional favorite, but is it overvalued?
With Apple Inc. (NASDAQ: AAPL) holding the No. 1 spot as the biggest S&P 500 component, and having posted a 2023 gain of 49.39% is the stock overvalued, or primed for a correction in 2024?
Even
Four beaten-down penny stocks ready to take off
Penny stocks are attractive simply because of the opportunity for exponential returns. Stocks like Alphabet Inc. (NASDAQ: GOOG), Microsoft Corporation (NASDAQ: MSFT) and Apple Inc. (NASDAQ: AAPL)
Eilt: Biotech Hot Stock heilt Hautkrebs vollständig - Massives Kaufsignal. Diese Biotech-Aktie jetzt kaufen nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Biotech Hot Stock heilt Hautkrebs vollständig - Kaufsignal. Diese Biotech-Aktie kaufen nach 15.973% mit BioNTech
29.12.23 08:03
London (www.aktiencheck.de, Anzeige)
Rivian is all set to start 2024 with a bang
As we head into 2024, the electric vehicle (EV) space remains one of the most closely watched by investors. All told it's had a decent year, but one that's far from its best. The Global X
Ray Dalio keeps adding to this ETF, what's he thinking?
Last quarter, it became evident to thousands of investors just like you just how bullish Ray Dalio had become on Asian markets. Still, while most thought it was a one-time allocation to gain the